loading

Finanzdaten der Greenwich Lifesciences Inc-Aktie (GLSI)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
23.26%
4.046
3.2823 8.0842 2.7291 2.6614
Operating Income/Loss
23.26%
-4.046
-3.2823 -8.0842 -2.7291 -2.6614
Income/Loss From Continuing Operations Before Tax
23.54%
-4.0253
-3.2584 -8.0402 -2.6687 -2.6067
Income/Loss From Continuing Operations After Tax
23.54%
-4.0253
-3.2584 -8.0402 -2.6687 -2.6067
Net Income/Loss
23.54%
-4.0253
-3.2584 -8.0402 -2.6687 -2.6067
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1.51%
13.37
13.17 0.0445 13.14 12.91
Diluted Average Shares
1.51%
13.37
13.17 0.0445 13.14 12.91
Basic Earnings Per Share
20.00%
-0.30
-0.25 -0.61 -0.20 -0.20
Diluted Earnings Per Share
20.00%
-0.30
-0.25 -0.61 -0.20 -0.20
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$25.23
price up icon 1.78%
$84.09
price down icon 0.61%
$25.31
price up icon 1.75%
$102.39
price down icon 0.60%
$135.11
price up icon 0.51%
biotechnology ONC
$298.42
price down icon 0.66%
Kapitalisierung:     |  Volumen (24h):